✨ Your Portfolio is fetched and updated from zerodha.
Small Hospitals
Market Cap
₹9,654 Cr.
P/E
67.47

Key Ratios

Market cap
Market cap
9,654 Cr
PE
PE
67.47
Prom Holding
Prom Holding
53.05 %
ROE (%)
ROE (%)
18.08
ROCE (%)
ROCE (%)
20.37
Div Yield (%)
Div Yield (%)
0.11
Sales
Sales
681 Cr
OPM (%)
OPM (%)
40.10 %
Debt to Equity
Debt to Equity
-
About
Vijaya Diagnostic Centre Limited is a rapidly expanding diagnostic chain in Southern India, of… Read more
Low
730
52W Range
High
1275
  • Vijaya Diagnostic
  • Metropolis Health.
  • Thyrocare Tech.
  • TJI Diagnostic Chains

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

7 Yes

Positive for this company

3 Neutral

Neutral for this company

5 No

Negative for this company

2 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Distribution Channel

Operational Metrics

    Select a Metric
    • Number of Diagnostic Centres (.)
    • Realization/Test - Diagnostic Centres (Rs/Test)
    • Operating Margin/Test - Diagnostic Centres (Rs/Test)
    • No of Tests - Quarterly (Mn)
    • Revenue per Footfall (Rs)
    • Quarterly Footfalls (Lakh)
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on Vijaya Diagnostic Centre Ltd. Business

    Vijaya Diagnostic Centre Limited is a leading diagnostic chain in Southern India offering a comprehensive range of pathology and radiology tests, specialized services, and personalized health packages.

    Vijaya Diagnostic major competitors are Metropolis Health., Thyrocare Tech., Krsnaa Diagnostics, Vimta Labs, Nidan Labs. & Health, Dr. Lal Pathlabs, Medplus Health Servi.
    Market Cap of Vijaya Diagnostic is ₹9,654 Crs.
    While the median market cap of its peers are ₹5,064 Crs.

    Vijaya Diagnostic seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release May Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Sep Dec
    Investor Presentation May Mar Jun Sep Dec Mar Jun Sep Dec Feb Mar May Jun Aug Sep Dec Sep Dec
    Conference Call Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Sep Dec
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material